EGFR and non-small cell lung carcinoma: For the first time, we identified that decreases the activity of the EGFR‐Akt‐cyclin D1 signaling pathway was one of the major underlying mechanisms for oxymatrine‐induced cell cycle arrest in human NSCLC.